This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Chinese Academy of Sciences. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Lun Xiong: Innovator in Pharmaceutical Chemistry
Introduction
Lun Xiong is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at combating bacterial infections. His innovative work has led to the creation of a valuable patent that addresses critical health challenges.
Latest Patents
Lun Xiong holds a patent for a vancomycin derivative, which includes a preparation method, pharmaceutical composition, and its use in treating bacterial infections. This patent presents a class of vancomycin derivatives with a specific structure and pharmaceutically acceptable salts. The compounds are designed for preparing drugs that treat and prevent diseases caused by Gram-positive bacteria, showcasing their potential in the pharmaceutical industry.
Career Highlights
Lun Xiong is affiliated with the Chinese Academy of Sciences, where he conducts research and development in pharmaceutical sciences. His work has been instrumental in advancing the understanding and treatment of bacterial infections, contributing to public health.
Collaborations
Lun Xiong collaborates with notable colleagues, including Lefu Lan and Dongliang Guan. Their combined expertise enhances the research efforts at the Chinese Academy of Sciences, fostering innovation in pharmaceutical development.
Conclusion
Lun Xiong's contributions to pharmaceutical chemistry, particularly through his patent on vancomycin derivatives, highlight his role as an innovator in the field. His work not only advances scientific knowledge but also has the potential to improve treatment options for bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
